Stock Analysis on Net
Stock Analysis on Net

Gilead Sciences Inc. (NASDAQ:GILD)

$24.99

Statement of Comprehensive Income

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Paying user area

Try for free

Gilead Sciences Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Gilead Sciences Inc., consolidated statement of comprehensive income

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income
Net foreign currency translation gain (loss)
Net unrealized gain (loss), net of tax
Reclassifications to net income, net of tax
Available-for-sale debt securities, net change
Net unrealized gain (loss), net of tax
Reclassifications to net income, net of tax
Cash flow hedges, net change
Other comprehensive income (loss), net
Comprehensive income (loss), net
Comprehensive loss attributable to noncontrolling interest, net
Comprehensive income (loss) attributable to Gilead, net

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Comprehensive income item Description The company
Net income attributable to Gilead The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Gilead Sciences Inc. net income attributable to Gilead decreased from 2021 to 2022 but then increased from 2022 to 2023 not reaching 2021 level.
Comprehensive income (loss) attributable to Gilead, net Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Gilead Sciences Inc. comprehensive income (loss) attributable to Gilead, net decreased from 2021 to 2022 but then increased from 2022 to 2023 not reaching 2021 level.